Skip to main content

Peer Review reports

From: Provider perspectives on the acceptability and tolerability of dolutegravir-based anti-retroviral therapy after national roll-out in Uganda: a qualitative study

Original Submission
30 Jun 2021 Submitted Original manuscript
27 Aug 2021 Reviewed Reviewer Report
24 Sep 2021 Reviewed Reviewer Report - Adelline Twimukye
23 Oct 2021 Author responded Author comments - Henry Zakumumpa
27 Oct 2021 Author responded Author comments - Henry Zakumumpa
Resubmission - Version 2
23 Oct 2021 Submitted Manuscript version 2
31 Oct 2021 Author responded Author comments - Henry Zakumumpa
Resubmission - Version 3
31 Oct 2021 Submitted Manuscript version 3
23 Nov 2021 Reviewed Reviewer Report - Adelline Twimukye
29 Nov 2021 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
30 Nov 2021 Editorially accepted
7 Dec 2021 Article published 10.1186/s12879-021-06933-8

You can find further information about peer review here.

Back to article page